FDA seeks active system for monitoring adverse events

被引：0
|
作者：
Wechsler, Jill
机构：
来源：
BIOPHARM INTERNATIONAL | 2008年 / 21卷 / 08期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：14 / +
页数：2
相关论文
共 50 条
  • [11] FDA adverse events medwatch program
    D. John Doyle
    Canadian Journal of Anaesthesia, 2000, 47 (11) : 1148 - 1149
  • [12] ‘Extreme Duplication’ in the US FDA Adverse Events Reporting System Database
    Manfred Hauben
    Lester Reich
    James De Micco
    Katherine Kim
    Drug Safety, 2007, 30 : 551 - 554
  • [13] A pharmacovigilance analysis of FDA adverse event reporting system events for romosozumab
    Chen, Zepeng
    Li, Ming
    Li, Shuzhen
    Li, Yuxi
    Wu, Junyan
    Qiu, Kaifeng
    Yu, Xiaoxia
    Huang, Lin
    Chen, Guanghui
    EXPERT OPINION ON DRUG SAFETY, 2023, 22 (04) : 339 - 342
  • [14] Biclustering of Adverse Drug Events in the FDA's Spontaneous Reporting System
    Harpaz, R.
    Perez, H.
    Chase, H. S.
    Rabadan, R.
    Hripcsak, G.
    Friedman, C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (02) : 243 - 250
  • [15] A disproportionality analysis of FDA adverse event reporting system events for misoprostol
    Yang, Li
    Xu, Wenting
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [16] Adverse events associated with brolucizumab: a disproportionality analysis of the FDA adverse event reporting system (FAERS)
    Xiong, Xiaomei
    Zhang, Xiuwen
    Li, Xiaoxia
    Huang, Taomin
    EXPERT OPINION ON DRUG SAFETY, 2024, 23 (11) : 1447 - 1452
  • [17] Serious Adverse Drug Events Reported to the FDA: Analysis of the FDA Adverse Event Reporting System 2006-2014 Database
    Sonawane, Kalyani B.
    Cheng, Ning
    Hansen, Richard A.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (07): : 682 - 690
  • [18] RHEUMATOLOGICAL IMMUNE-MEDIATED ADVERSE EVENTS OF IMMUNE CHECKPOINT INHIBITORS BASED ON THE FDA ADVERSE EVENTS REPORTING SYSTEM
    Rodriguez-Pla, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1824 - 1825
  • [19] Cardiac adverse events associated with quetiapine: Disproportionality analysis of FDA adverse event reporting system
    Shu, Yamin
    Ding, Yiling
    Liu, Lulu
    Zhang, Qilin
    CNS NEUROSCIENCE & THERAPEUTICS, 2023, 29 (09) : 2705 - 2716
  • [20] A disproportionality analysis of adverse events associated to pertuzumab in the FDA Adverse Event Reporting System (FAERS)
    Shu-peng Zou
    Hai-yun Yang
    Meng-ling Ouyang
    Qian Cheng
    Xuan Shi
    Ming-hui Sun
    BMC Pharmacology and Toxicology, 24
12345